Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Brichacek B, Vanpouille C, Kiselyeva Y, Biancotto A, Merbah M, Hirsch I, Lisco A, Grivel JC, Margolis L.

PLoS One. 2010 Sep 20;5(9). pii: e12831. doi: 10.1371/journal.pone.0012831.

2.

Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1.

Morrow MP, Grant A, Mujawar Z, Dubrovsky L, Pushkarsky T, Kiselyeva Y, Jennelle L, Mukhamedova N, Remaley AT, Kashanchi F, Sviridov D, Bukrinsky M.

Mol Pharmacol. 2010 Aug;78(2):215-25. doi: 10.1124/mol.110.065029. Epub 2010 May 17.

3.

Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations.

Kiselyeva Y, Nedellec R, Ramos A, Pastore C, Margolis LB, Mosier DE.

J Virol. 2007 Apr;81(7):3657-61. Epub 2007 Jan 3.

4.
5.

Depletion of CD4 T lymphocytes in human lymphoid tissue infected ex vivo with doxycycline-dependent HIV-1.

Kiselyeva Y, Ito Y, Lima RG, Grivel JC, Das AT, Berkhout B, Margolis LB.

Virology. 2004 Oct 10;328(1):1-6.

6.

CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.

Ito Y, Grivel JC, Chen S, Kiselyeva Y, Reichelderfer P, Margolis L.

J Infect Dis. 2004 Feb 1;189(3):506-14. Epub 2004 Jan 20.

PMID:
14745709

Supplemental Content

Loading ...
Support Center